Jeff Bittiger cause of death: Legendary baseball pitcher dies. Check stats, key achievements
, a pitcher who played four seasons in the major leagues and spent the last 22 years as a scout in the Athletics organization, died Saturday morning, the A's announced. He was 63-year-old. The team did not disclose a cause of death.
Born in Jersey City, New Jersey, Bittiger made his major league debut for Philadelphia on Sept. 2, 1986. The 5-foot-10 right-hander went 4-6 with a 4.77 ERA in 33 appearances for the Phillies, Minnesota Twins and Chicago White Sox.
Explore courses from Top Institutes in
Select a Course Category
He pitched his last major league game in 1989 for Chicago, and the A's said he continued to play independent ball until age 40.
As an area scout for the A's, Bittiger signed right-hander Andrew Bailey, the AL Rookie of the Year in 2009, and he was part of the team's professional scouting staff for the past decade.
'Jeff spent his whole life around the game: playing, coaching, and scouting. He was as good a person as he was a scout, and he was a hell of a scout,' Billy Beane, a senior adviser to Athletics owner John Fisher who previously served as the club's general manager, said in a statement. 'He knew pitchers inside and out and you could tell how much he loved baseball just by being around him.'
Live Events
FAQs
Q1. What was age of Jeff Bittiger?
A1. Jeff Bittiger was 63-year-old.
Q2. Which teams did Jeff Bittiger play for?
A2. Born in Jersey City, New Jersey, Jeff Bittiger made his major league debut for Philadelphia on Sept. 2, 1986. The 5-foot-10 right-hander went 4-6 with a 4.77 ERA in 33 appearances for the Phillies, Minnesota Twins and Chicago White Sox.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
2 days ago
- Mint
Carlos Correa trade: Houston Astros to reacquire star in blockbuster deal with Minnesota Twins ahead of MLB deadline
The Minnesota Twins are trading shortstop Carlos Correa back to the Houston Astros, in a jaw-dropping move hours before the 2025 MLB trade deadline, according to reports. This blockbuster deal sees the former All-Star waive his no-trade clause and agree to play third base alongside Jeremy Pena, marking a stunning reunion with the team he helped lead to a 2017 World Series title. Carlos Correa's contract, with $91.5 million owed from 2026 to 2028 and vesting options through 2032, posed a challenge. The Twins, navigating an ownership transition, are expected to absorb part of the salary to facilitate the trade, easing Houston's luxury tax concerns. This financial maneuver aligns with Minnesota's strategy to reduce payroll while Houston strengthens its roster for a postseason push. Carlos Correa, a three-time All-Star and 2015 AL Rookie of the Year with the Astros, is currently with the Minnesota Twins. He has underperformed in 2025, posting a .267/.319/.386 slash line with 7 home runs in 93 games. This is a noticeable dip from his 2024 season, where he hit .310/.388/.517 in 86 games despite injuries. Carlos Correa, 30, was the face of the Houston Astros' golden era from 2015 to 2021, earning Rookie of the Year honors and two All-Star nods. His return will address a critical need for Houston, as third baseman Isaac Paredes faces a season-ending hamstring injury. Correa's willingness to shift positions highlights his commitment to winning, reigniting Astros fans' hopes for another championship run. The Astros also added left-handed outfielder Jesus Sanchez from the Miami Marlins to their lineup, adding power and control through 2027.
Time of India
3 days ago
- Time of India
Track and field sets Sept. 1 deadline for female eligibility gene tests ahead of worlds in Tokyo
World Athletics has set a September 1 deadline for athletes. They must pass a gene test to compete at the world championships. This clarifies rules on female eligibility. The move follows Caster Semenya's long legal battle. She challenged previous eligibility rules. The new rules require a 'once-in-a-lifetime test'. This test determines athletes' biological sex. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Clarifying promised rules on female eligibility, track and field's governing body set a Sept. 1 deadline Wednesday for athletes to pass a gene test for competing at the world championships. World Athletics said in March it would require chromosome testing by cheek swabs or dry blood-spot tests for female athletes to be eligible for elite-level next worlds open Sept. 13 in Tokyo and Sept. 1 is "the closing date for entries and the date the regulations come into effect," World Athletics said in a latest rules update gives certainty for the 2025 championships in an issue that has been controversial on the track and in multiple courts since Caster Semenya won her first 800 meters world title as a teenager in won a ruling at the European Court of Human Rights three weeks ago in Strasbourg, France, in the South Africa star's years-long challenge to a previous version of track and field's eligibility rules affecting athletes with medical conditions known as Differences in Sex Development . That legal win because she did not get a fair hearing at the Swiss supreme court did not overturn track's Athletics drew up rules in 2018 forcing two-time Olympic champion Semenya and other athletes with DSD to suppress their elevated natural testosterone levels to be eligible for international women's events. Semenya refused to take the Monaco-based track body requires a "once-in-a-lifetime test" to determine athletes it says are biologically male with a Y chromosome."We are saying, at elite level, for you to compete in the female category, you have to be biologically female," World Athletics president Sebastian Coe governing body is covering up to $100 of the costs for each test with the protocol overseen by its member federations at national level. Test results should be ready within two weeks."The SRY test is extremely accurate and the risk of false negative or positive is extremely unlikely," World Athletics Athletics has combined its eligibility framework for DSD and transgender athletes, with transitional rules that let "a very small number of known DSD athletes" continue competing if they are taking medication to suppress natural testosterone."The transitional provisions do not apply to transgender women as there are none competing at the elite international level under the current regulations," World Athletics age 34, and her track career effectively over, Semenya should now see her legal case go back to the Swiss federal court in Lausanne, where she lost her original appeal against track and field's rules at the Court of Arbitration for Sport.
Mint
3 days ago
- Mint
Carlos Correa's Astros homecoming? Trade talks heat up ahead of MLB deadline
Carlos Correa, the 2017 World Series hero, could be headed back to the Houston Astros. With the MLB trade deadline looming on Thursday (July 31), the Astros are reportedly targeting the star player alongside Nolan Arenado and Eugenio Suarez to strengthen their injury-hit infield. The Houston Astros, leading the AL West by four games as of July 30, 2025, are struggling with injuries. Notably, the All-Star third baseman Isaac Paredes suffered a hamstring strain on July 19 and may require season-ending surgery. This gap has prompted the Astros to seek infield reinforcements to maintain their playoff edge. Shortstop Jeremy Pena, dealing with a rib injury, is almost back after practicing in the minor leagues. The team's offense has been weak this July, so they're looking for players like Carlos Correa to add some power at the plate. Carlos Correa, a former Astro and key contributor to their 2017 World Series title, is a familiar name. His reported willingness to waive his no-trade clause to return to Houston, where he and his family reside in the offseason, added fuel to the potential trade. Carlos Correa, a three-time All-Star and 2015 AL Rookie of the Year with the Astros, is currently with the Minnesota Twins. He has underperformed in 2025, posting a .267/.319/.386 slash line with 7 home runs in 93 games. This is a noticeable dip from his 2024 season, where he hit .310/.388/.517 in 86 games despite injuries. A major hurdle in any potential trade is Carlos Correa's hefty contract. He is owed $37.3 million for 2025 and $96 million from 2026 to 2028, with vesting options for 2029-2032 that could add up to $70 million more if performance thresholds are met. Moreover, his deal includes a full no-trade clause, but reports indicate Correa would waive it to return to Houston. However, the Astros are wary of the financial commitment, especially after entering luxury tax territory last season. For a deal to work, the Twins would likely need to absorb a significant portion of Correa's salary. If Correa joins the Astros, he would likely play third base since Jeremy Pena is their main shortstop and plays great defense. Correa has never played third base in the majors, but he was willing to try it in a past deal that didn't work out. The Minnesota Twins, sitting at 51-56 and expected to sell at the deadline, face a complex decision. Correa's contract and no-trade clause make him a challenging asset to move, but his willingness to return to Houston opens the door. The Twins may prioritize shedding his salary over maximizing trade returns, especially with other controllable assets like relievers Jhoan Duran and Griffin Jax drawing interest.
